SS Innovations International Inc. (NASDAQ: SSII) has supported the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery (LIMA) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This milestone was highlighted in a recent company video describing the program's early activity, which noted that Kings Hospital has completed more than 25 robotic procedures in just three weeks.
The introduction of robotic cardiac surgery in Sri Lanka represents a significant advancement for the country's healthcare sector, potentially improving surgical precision, reducing recovery times, and expanding access to minimally invasive cardiac care. For SS Innovations, this launch demonstrates the global applicability of its SSi Mantra system and supports the company's strategy to penetrate new markets. As of the end of the second quarter, SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries. The company's second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, indicating rising utilization of its installed base.
These figures suggest growing adoption of robotic-assisted surgery worldwide, which could lead to better patient outcomes and more efficient healthcare delivery. The next major corporate milestone for SS Innovations is regulatory expansion, with the company pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Achieving these certifications would allow SS Innovations to enter two of the largest medical device markets, potentially accelerating revenue growth and broadening its competitive footprint against established robotic surgery players.
For readers in the health and medical industries, this development underscores the increasing globalization of robotic surgery and the importance of regulatory approvals in bringing advanced technologies to new regions. It also highlights the role of strategic partnerships with local hospitals in driving adoption. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. As robotic surgery continues to evolve, SS Innovations' progress in Sri Lanka and its regulatory pursuits will be key indicators of its ability to compete in a rapidly changing market. The company's performance and expansion efforts are likely to be closely watched by investors and healthcare providers alike.
